EASL 2013 - Annual Meeting of European Association for the Study of the Liver
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:
What you need to know
> Blogs > Hep Exclusives > Hepatitis News > Lessons

100% Cured with Combo

After promising hep C trials, docs are thinking about prescribing the drug blend "off-label."

80% Cured

Protease inhibitor, Simeprevir cured 4 out of 5 people with hepatitis C in Janssen's phase III clinical trials.

5 Drugs,
12 Weeks

AbbVie's five-drug HCV combo therapy demonstrated over 90% cure rates in phase IIb studies.

The Perfect Combination?

BMS is boasting high cure rates with its all-oral interferon and ribavirin-free hep C combination treatment.

2 HIV Drugs Might Control Hepatitis B

Combo therapy suppresses "immune-tolerant" HBV infections in 75% of trial participants.

EASL 2013 Kicks Off

Visit the event's main website for more information.

EASL Coverage

Footage from the front lines
Jose Oliva, MD, an Allegheny General Hospital hepatologist and medical director of the medical center's liver transplant program, speaks with NBC Nightly News about the Hepatitis C epidemic and how it is affecting baby boomers.
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.